Improve Medical Instruments Co Ltd
SZSE:300030
Income Statement
Earnings Waterfall
Improve Medical Instruments Co Ltd
Revenue
|
653.6m
CNY
|
Cost of Revenue
|
-415.5m
CNY
|
Gross Profit
|
238.1m
CNY
|
Operating Expenses
|
-387.3m
CNY
|
Operating Income
|
-149.2m
CNY
|
Other Expenses
|
11.9m
CNY
|
Net Income
|
-137.3m
CNY
|
Income Statement
Improve Medical Instruments Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
351
N/A
|
397
+13%
|
409
+3%
|
440
+8%
|
463
+5%
|
462
0%
|
476
+3%
|
498
+5%
|
512
+3%
|
545
+7%
|
558
+2%
|
538
-4%
|
536
0%
|
517
-3%
|
521
+1%
|
528
+1%
|
534
+1%
|
550
+3%
|
564
+3%
|
574
+2%
|
566
-1%
|
550
-3%
|
537
-2%
|
550
+2%
|
568
+3%
|
575
+1%
|
612
+6%
|
718
+17%
|
787
+10%
|
919
+17%
|
1 002
+9%
|
934
-7%
|
886
-5%
|
800
-10%
|
749
-6%
|
736
-2%
|
740
+1%
|
711
-4%
|
690
-3%
|
678
-2%
|
654
-4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(206)
|
(230)
|
(241)
|
(265)
|
(268)
|
(262)
|
(269)
|
(278)
|
(293)
|
(309)
|
(321)
|
(304)
|
(299)
|
(277)
|
(284)
|
(285)
|
(296)
|
(304)
|
(323)
|
(335)
|
(329)
|
(335)
|
(331)
|
(335)
|
(345)
|
(319)
|
(349)
|
(388)
|
(423)
|
(499)
|
(545)
|
(546)
|
(531)
|
(491)
|
(475)
|
(458)
|
(463)
|
(475)
|
(446)
|
(439)
|
(416)
|
|
Gross Profit |
144
N/A
|
167
+15%
|
168
+1%
|
175
+4%
|
195
+11%
|
200
+3%
|
208
+4%
|
219
+6%
|
219
0%
|
237
+8%
|
237
+0%
|
234
-1%
|
237
+1%
|
240
+2%
|
237
-1%
|
244
+3%
|
238
-2%
|
245
+3%
|
242
-2%
|
239
-1%
|
237
-1%
|
215
-10%
|
206
-4%
|
215
+4%
|
223
+4%
|
256
+15%
|
263
+3%
|
330
+25%
|
364
+10%
|
420
+16%
|
457
+9%
|
387
-15%
|
355
-8%
|
309
-13%
|
274
-11%
|
278
+1%
|
277
0%
|
236
-15%
|
244
+3%
|
240
-2%
|
238
-1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(114)
|
(126)
|
(126)
|
(130)
|
(137)
|
(152)
|
(152)
|
(162)
|
(172)
|
(195)
|
(196)
|
(199)
|
(204)
|
(203)
|
(195)
|
(197)
|
(188)
|
(190)
|
(191)
|
(187)
|
(192)
|
(221)
|
(328)
|
(329)
|
(336)
|
(212)
|
(209)
|
(242)
|
(255)
|
(305)
|
(329)
|
(319)
|
(299)
|
(269)
|
(279)
|
(274)
|
(293)
|
(292)
|
(389)
|
(390)
|
(387)
|
|
Selling, General & Administrative |
(113)
|
(100)
|
(125)
|
(128)
|
(136)
|
(117)
|
(149)
|
(158)
|
(168)
|
(153)
|
(196)
|
(199)
|
(204)
|
(158)
|
(193)
|
(195)
|
(184)
|
(167)
|
(193)
|
(192)
|
(194)
|
(193)
|
(194)
|
(188)
|
(195)
|
(181)
|
(202)
|
(221)
|
(224)
|
(259)
|
(274)
|
(277)
|
(266)
|
(218)
|
(230)
|
(225)
|
(241)
|
(235)
|
(237)
|
(240)
|
(234)
|
|
Research & Development |
0
|
(19)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
(4)
|
(19)
|
0
|
0
|
(7)
|
(24)
|
(18)
|
(24)
|
(21)
|
(20)
|
(25)
|
(28)
|
(36)
|
(43)
|
(49)
|
(50)
|
(47)
|
(39)
|
(43)
|
(44)
|
(45)
|
(40)
|
(44)
|
(42)
|
(40)
|
|
Depreciation & Amortization |
0
|
(7)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
1
|
14
|
3
|
4
|
10
|
15
|
(115)
|
(117)
|
(120)
|
9
|
17
|
8
|
6
|
15
|
(5)
|
8
|
14
|
17
|
(5)
|
(5)
|
(6)
|
10
|
(108)
|
(108)
|
(113)
|
|
Operating Income |
31
N/A
|
40
+32%
|
42
+3%
|
46
+9%
|
58
+27%
|
48
-16%
|
56
+15%
|
57
+3%
|
46
-19%
|
41
-11%
|
41
-1%
|
36
-13%
|
33
-8%
|
37
+13%
|
43
+15%
|
47
+10%
|
50
+8%
|
55
+9%
|
51
-8%
|
52
+1%
|
45
-12%
|
(7)
N/A
|
(122)
-1 688%
|
(114)
+6%
|
(112)
+1%
|
44
N/A
|
54
+23%
|
88
+64%
|
109
+24%
|
115
+6%
|
128
+12%
|
68
-47%
|
55
-19%
|
40
-27%
|
(4)
N/A
|
4
N/A
|
(16)
N/A
|
(56)
-239%
|
(145)
-161%
|
(150)
-3%
|
(149)
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
3
|
4
|
5
|
5
|
5
|
5
|
2
|
(1)
|
(2)
|
(3)
|
(6)
|
(8)
|
(12)
|
(12)
|
(17)
|
(22)
|
(28)
|
(28)
|
(35)
|
(30)
|
(24)
|
(29)
|
(21)
|
(23)
|
(17)
|
(6)
|
(10)
|
36
|
113
|
62
|
64
|
86
|
(66)
|
(8)
|
(41)
|
(104)
|
(46)
|
(69)
|
(16)
|
(17)
|
(9)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(10)
|
0
|
0
|
1
|
(109)
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
(11)
|
(0)
|
(0)
|
(0)
|
(2)
|
0
|
(0)
|
(0)
|
(90)
|
(0)
|
0
|
5
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
15
|
15
|
16
|
16
|
12
|
12
|
12
|
12
|
9
|
12
|
12
|
15
|
16
|
16
|
15
|
15
|
13
|
0
|
(2)
|
(6)
|
(6)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(6)
|
(6)
|
(5)
|
(6)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Pre-Tax Income |
49
N/A
|
60
+22%
|
62
+4%
|
66
+6%
|
75
+12%
|
66
-12%
|
69
+5%
|
68
-2%
|
53
-22%
|
50
-7%
|
47
-5%
|
42
-10%
|
37
-13%
|
41
+10%
|
41
N/A
|
40
-2%
|
35
-11%
|
17
-52%
|
14
-15%
|
17
+15%
|
16
-5%
|
(145)
N/A
|
(143)
+1%
|
(137)
+4%
|
(130)
+5%
|
37
N/A
|
43
+17%
|
123
+184%
|
221
+80%
|
165
-25%
|
192
+16%
|
152
-20%
|
(12)
N/A
|
24
N/A
|
(51)
N/A
|
(105)
-106%
|
(69)
+35%
|
(214)
-213%
|
(163)
+24%
|
(168)
-3%
|
(154)
+9%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(7)
|
(8)
|
(9)
|
(9)
|
(11)
|
(9)
|
(10)
|
(11)
|
(8)
|
(9)
|
(7)
|
(6)
|
(5)
|
(10)
|
(11)
|
(11)
|
(11)
|
(9)
|
(9)
|
(9)
|
(8)
|
4
|
4
|
2
|
(2)
|
(11)
|
(11)
|
(8)
|
(10)
|
(2)
|
(6)
|
(5)
|
1
|
(4)
|
0
|
(0)
|
(2)
|
21
|
21
|
22
|
22
|
|
Income from Continuing Operations |
42
|
52
|
53
|
58
|
64
|
57
|
59
|
57
|
45
|
41
|
40
|
36
|
32
|
31
|
29
|
29
|
24
|
8
|
6
|
7
|
8
|
(141)
|
(140)
|
(136)
|
(132)
|
26
|
33
|
115
|
212
|
163
|
185
|
148
|
(11)
|
20
|
(51)
|
(105)
|
(70)
|
(193)
|
(142)
|
(147)
|
(132)
|
|
Income to Minority Interest |
(3)
|
(5)
|
(4)
|
(5)
|
(6)
|
(4)
|
(5)
|
(5)
|
(4)
|
(1)
|
(1)
|
1
|
1
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
3
|
4
|
4
|
3
|
3
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
Net Income (Common) |
39
N/A
|
46
+19%
|
50
+8%
|
53
+6%
|
58
+10%
|
53
-8%
|
55
+3%
|
52
-5%
|
41
-20%
|
40
-4%
|
39
-2%
|
37
-6%
|
32
-12%
|
31
-6%
|
29
-4%
|
29
0%
|
24
-18%
|
11
-53%
|
9
-22%
|
11
+23%
|
11
+6%
|
(137)
N/A
|
(136)
+1%
|
(133)
+2%
|
(129)
+3%
|
26
N/A
|
33
+25%
|
115
+254%
|
211
+83%
|
163
-23%
|
185
+14%
|
147
-20%
|
(11)
N/A
|
19
N/A
|
(52)
N/A
|
(107)
-105%
|
(73)
+32%
|
(198)
-170%
|
(147)
+26%
|
(152)
-3%
|
(137)
+10%
|
|
EPS (Diluted) |
0.13
N/A
|
0.16
+23%
|
0.17
+6%
|
0.18
+6%
|
0.19
+6%
|
0.18
-5%
|
0.18
N/A
|
0.17
-6%
|
0.14
-18%
|
0.13
-7%
|
0.13
N/A
|
0.12
-8%
|
0.1
-17%
|
0.1
N/A
|
0.09
-10%
|
0.09
N/A
|
0.08
-11%
|
0.04
-50%
|
0.03
-25%
|
0.04
+33%
|
0.04
N/A
|
-0.44
N/A
|
-0.44
N/A
|
-0.43
+2%
|
-0.42
+2%
|
0.08
N/A
|
0.11
+38%
|
0.38
+245%
|
0.69
+82%
|
0.53
-23%
|
0.6
+13%
|
0.47
-22%
|
-0.04
N/A
|
0.06
N/A
|
-0.17
N/A
|
-0.35
-106%
|
-0.24
+31%
|
-0.64
-167%
|
-0.48
+25%
|
-0.49
-2%
|
-0.44
+10%
|